← Browse by Condition
Medical Condition
respiratory tract infections
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4, Phase 3
ClinicalMetric tracks all active clinical trials for respiratory tract infections sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — respiratory tract infections Clinical Trials
How many clinical trials are currently recruiting for respiratory tract infections?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for respiratory tract infections, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for respiratory tract infections?
respiratory tract infections research spans Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a respiratory tract infections clinical trial?
Eligibility criteria for respiratory tract infections trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 2
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05758532 Phase 4
Recruiting
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
Enrollment
500 pts
Location
Switzerland
Sponsor
Laure Pittet, MD-PhD
NCT06570889 Phase 3
Recruiting
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Enrollment
2,000 pts
Location
Denmark
Sponsor
Professor Klaus Bønnelykke
NCT02979951
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
Enrollment
1,000 pts
Location
Austria, Germany, Gr...
Sponsor
Infectopharm Arzneimittel GmbH
NCT03299608
Recruiting
Rapid Analysis of Infections by Spectrometry of Exhaled Breath
Enrollment
246 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT06560255 Phase 3
Recruiting
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Enrollment
2,000 pts
Location
Denmark
Sponsor
Professor Klaus Bønnelykke
NCT06495021
Recruiting
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Enrollment
68 pts
Location
United States
Sponsor
Geisinger Clinic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology